Edwin Gale

10.3k total citations · 1 hit paper
74 papers, 6.6k citations indexed

About

Edwin Gale is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Edwin Gale has authored 74 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Endocrinology, Diabetes and Metabolism, 33 papers in Genetics and 25 papers in Surgery. Recurrent topics in Edwin Gale's work include Diabetes Management and Research (41 papers), Diabetes and associated disorders (30 papers) and Pancreatic function and diabetes (24 papers). Edwin Gale is often cited by papers focused on Diabetes Management and Research (41 papers), Diabetes and associated disorders (30 papers) and Pancreatic function and diabetes (24 papers). Edwin Gale collaborates with scholars based in United Kingdom, United States and Italy. Edwin Gale's co-authors include Polly J. Bingley, Ezio Bonifacio, Alistair J.K. Williams, Robert S. Sherwin, M. Sue Kirkman, Richard M. Bergenstal, Peter D. Reaven, Barbara V. Howard, John B. Buse and Prakash Deedwania and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

In The Last Decade

Edwin Gale

72 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

2008 637 citations Jay S. Skyler, Richard M. Bergenstal et al. Diabetes Care profile →

Peers

Countries citing papers authored by Edwin Gale

Since Specialization

Citations

This map shows the geographic impact of Edwin Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Gale more than expected).

Fields of papers citing papers by Edwin Gale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Gale. The network helps show where Edwin Gale may publish in the future.

Co-authorship network of co-authors of Edwin Gale

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Gale. A scholar is included among the top collaborators of Edwin Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Gale. Edwin Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The insulin market reaches 100 2022 ·Diabetologia ·David Beran, Edwin Gale, John Yudkin	2
2	The challenge of diabetes in sub-Saharan Africa 2015 ·The Lancet Diabetes & Endocrinology ·Rifat Atun, Edwin Gale	34
3	Productivity of authors in the field of diabetes: bibliographic analysis of trial publications 2015 ·BMJ ·F. Holleman, (unknown), (unknown), Edwin Gale	12
4	A Critical Analysis of the Clinical Use of Incretin-Based Therapies 2013 ·Diabetes Care ·Peter C. Butler, Michael Elashoff, Robert M. Elashoff, Edwin Gale	226
5	Intensified glucose control in type 2 diabetes—whose agenda? 2010 ·The Lancet ·John Yudkin, Bernd Richter, Edwin Gale	26
6	Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials 2009 ·Journal of the American College of Cardiology ·Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, Prakash Deedwania, Edwin Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven, Robert S. Sherwin	364
7	Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials breakdown → 2008 ·Diabetes Care ·Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, Prakash Deedwania, Edwin Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven, Robert S. Sherwin	637
8	Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet β cell microchimerism 2007 ·Proceedings of the National Academy of Sciences ·J. Lee Nelson, Kathleen M. Gillespie, Nathalie Lambert, Anne M. Stevens, Laurence Loubière, Joe C. Rutledge, Wendy M. Leisenring, Timothy Erickson, Zhen Yan, (unknown), (unknown), Polly J. Bingley, Edwin Gale	147
9	Survival of the Fittest? Natural Selection in Islet Transplantation 2005 ·Transplantation ·Richard Smith, Edwin Gale	9
10	Between two cultures: the expert clinician and the pharmaceutical industry 2003 ·Clinical Medicine ·Edwin Gale	4
11	Should surgeons treat diabetes in severely obese people? 2001 ·The Lancet ·Jonathan Pinkney, C. David Sjöström, Edwin Gale	55
12	Measurement of nicotinamide andN-methyl-2-pyridone-5-carboxamide in plasma by high performance liquid chromatography 1999 ·Biomedical Chromatography ·(unknown), Colin H. Bolton, (unknown), W. Moore, David I. Perrett, Polly J. Bingley, Edwin Gale	11
13	Insulin lispro:a new quick-acting insulin analogue 1997 ·Expert Opinion on Investigational Drugs ·Edwin Gale	2
14	Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis 1997 ·BMJ ·(unknown), Polly J. Bingley, P Sawtell, (unknown), Edwin Gale	187
15	A Novel Micro-assay for Insulin Autoantibodies 1997 ·Journal of Autoimmunity ·Alistair J.K. Williams, Polly J. Bingley, Ezio Bonifacio, Jerry P. Palmer, Edwin Gale	193
16	Theory and Practice of Nicotinamide Trials in Pre-Type 1 Diabetes 1996 ·Journal of Pediatric Endocrinology and Metabolism ·Edwin Gale	42
17	New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2 1994 ·European Journal of Endocrinology ·Alberto Signore, M. Chianelli, Elisabetta Ferretti, (unknown), K. E. Britton, D Andreani, Edwin Gale, Paolo Pozzilli	22
18	Diabetes: clínica y tratamiento 1993 ·Dialnet (Universidad de la Rioja) ·Robert Tattersall, Edwin Gale	1
19	Treatment of Diabetic Neuropathy With γ-Linolenic Acid 1993 ·Diabetes Care ·H. Keen, (unknown), Jaffar Allawi, James D. Walker, G A Jamal, Andrew Weir, (unknown), (unknown), Peter Watkins, Michael Sampson, Edwin Gale, J. H. B. Scarpello, (unknown), Kevin Hardy, P. K. Thomas, Peter Misra, J.-P. Halonen	153
20	Diabetes : clinical management 1990 ·Churchill Livingstone eBooks ·Robert Tattersall, Edwin Gale	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact